The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
HYDROmorphone Hydrochloride 5mg/5mL (1mg/mL) Oral Solution, USP (Rhodes, USA)
Section 19A approved medicine
HYDROmorphone Hydrochloride 5mg/5mL (1mg/mL) Oral Solution, USP (Rhodes, USA)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Current
Indication(s)
Hydromorphone hydrochloride preparations are indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or otherwise inappropriate to provide sufficient management of pain.
Additional information
Note: CONTAINS SULFITES
The use of HYDROmorphone Hydrochloride 5mg/5mL (1mg/mL) Oral Solution, USP (Rhodes, USA) is contraindicated in patients with hypersensitivity to sulfite-containing medications.
Images
